Htaug13pg7.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Three-Dimensional Cone-Beam Computed Tomographic Sialography in the Diagnosis and Management of Primary Sjögren Syndrome: Report of 3 Cases
Imaging Science in Dentistry 2021; 51: 209-16 https://doi.org/10.5624/isd.20200313 Three-dimensional cone-beam computed tomographic sialography in the diagnosis and management of primary Sjögren syndrome: Report of 3 cases Nithin Thomas 1, Aninditya Kaur 2, Sujatha S. Reddy 3, Rakesh Nagaraju 3,*, Ravleen Nagi 4, Vidya Gurram Shankar 5 1Department of Oral Radiology, Maxillofacial Diagnostics, Cochin, India 2Department of Oral Radiology, DMD Imaging, Gurgaon, India 3Department of Oral Medicine and Radiology, Faculty of Dental Sciences, M.S. Ramaiah University of Applied Sciences, Bangalore, Karnataka, India 4Department of Oral Medicine and Radiology, Swami Devi Dyal Hospital and Dental College, Panchkula, Haryana, India 5Department of Public Health, Texila American University, Georgetown, Guyana ABSTRACT Sjögren syndrome is a chronic autoimmune inflammatory disease characterized by lymphocytic infiltration of exocrine glands, predominantly the parotid and lacrimal glands, thereby resulting in oral and ocular dryness. It has been reported to occur most frequently in women between 40 and 50 years of age. Sjögren syndrome has an insidious onset, is slowly progressive, and presents a wide range of clinical manifestations, leading to delays or challenges in the diagnosis. Early diagnosis of this condition is essential to prevent the associated complications that affect patients’ quality of life. This report presents 3 cases of Sjögren syndrome in female patients aged between 40 and 75 years who presented with complaints of persistent dry mouth -
Dry Mouth: a Clinical Guide on Causes, Effects and Treatments, DOI 10.1007/978-3-642-55154-3 214 Index
Index A autoimmune hepatitis , 16 Acupuncture, SGD management , 61 chronic infl ammatory bowel diseases , Adult stem cells , 201–203 15–16 Afferent signalling, MISGD , 39–40 chronic infl ammatory connective tissue Aggregatibacter actinomycetemcomitans , diseases , 9–14 87, 89, 96 endocrine diseases , 17–18 Alpha-2 adrenoceptor (α2Ad) agonists neurological diseases , 18–20 activation , 44–45 primary biliary cirrhosis , 16 central signalling , 43–44 primary sclerosing cholangitis , 16 Alzheimer’s disease (AD) , 19–20 sarcoidosis , 14 American College of Rheumatology Autoimmune hepatitis (AIH) , 16 (ACR) , 13 American-European classifi cation criteria, Sjögren’s syndrome , 9, 10 B Amifostine , 198 Battery-type approaches Amphetamine , 44 Challacombe scale , 107 Amyloidosis , 16 item content , 106 Anorexia nervosa , 23 summated rating scale , 108–111 Antimuscarinic effect , 42 visual analogue scale , 107–108 Arc therapies , 161 Bell’s palsy , 19 Artifi cial salivas BMS. See Burning mouth syndrome (BMS) acidic pH , 170 Bother 1 xerostomia index (BI1) , 130, 131 advantage , 181 Bother 5 xerostomia index (BI5) , 129–131 bioactives , 169 Bulimia nervosa , 23 carboxymethylcellulose/xanthan gum , 169 Burning mouth syndrome (BMS) , 20 composition , 169–170 defi ciency , 165 effi cacy , 168 C elasticity , 170, 171 Candida albicans , 86–87, 90, 94, 95 food proteins , 171 Carbonic anhydrase VI , 74 intraoral lubrication and hydration , Cell models of oral mucosa , 168 167–168 Cerebral palsy syndromes , 18 and natural salivas, physical properties , Cevimeline, MIX treatment , 46 170, 171 Challacombe scale , 4, 107 randomised controlled trial , 166 Chewing gum surface tension , 168 and lozenges , 177 usage , 167 and saliva substitutes , 46–47 viscosity , 165 SGD management , 59 Autoimmune diseases side effects , 59 amyloidosis , 16 sugar-free , 96, 123, 181–182 © Springer-Verlag Berlin Heidelberg 2015 213 G. -
Dental Journal (Majalah Kedokteran Gigi) 2020 December; 53(4): 187–190 Case Report
187 Dental Journal (Majalah Kedokteran Gigi) 2020 December; 53(4): 187–190 Case Report Burning mouth syndrome caused by xerostomia secondary to amlodipine Tengku Natasha Eleena binti Tengku Ahmad Noor Dental Officer of 609 Armed Forces Dental Clinic, Kuching, Sarawak, Malaysia ABSTRACT Background: Xerostomia, generally referred to as dry mouth, has been identified as a side effect of more than 1,800 drugs from more than 80 groups. This condition is frequently unrecognised and untreated but may affect patients’ quality of life and cause problems with oral and medical health, including burning mouth syndrome (BMS). Purpose: The purpose of this case is to discuss how to manage a patient with BMS caused by xerostomia secondary to medication that has been taken by the patient. Case: We reported that a 45-year-old male military officer from the Royal Malaysian Air Force came to Kuching Armed Forces Dental Clinic with dry mouth and a burning sensation since he started taking 10 mg of amlodipine due to his hypertension. After a thorough physical and history examination, we made a diagnosis of burning mouth syndrome (BMS) caused by xerostomia secondary to amlodipine. Case Management: Oral hygiene instructions, diet advice and prescription of Oral7 mouthwash has been given to reduce the symptoms of BMS. The patient has been referred to the general practitioner to reduce his amlodipine dosage from 10 mg to 5 mg (OD) in order to prevent xerostomia, and oral hygiene instructions have been given. A review after two weeks showed significant changes in the oral cavity, and the patient was satisfied as he is no longer feeling the burning sensation and can enjoy his food without feeling difficulty in chewing and swallowing. -
The Dental Management of a Mouth Cancer Patient
Mouth Cancer Themed Issue Mouth cancer CLINICAL The dental management of a mouth cancer patient N. G. Beacher*1 and M. P. Sweeney1 Key points Promotes the role of all members of the dental Reviews current evidence and practice for dentists Explores new techniques and strategies available team in the management of patients with mouth in relation to the provision of dental care for mouth to aid in the oral healthcare of patients with mouth cancer. cancer patients. cancer. Dentists and dental care professionals have a key role to play in the journey of the mouth cancer patient. Involved in the prevention, diagnosis and delivery of oral healthcare before, during and following mouth cancer treatment, dental professionals are essential to the delivery of patient care. This article will explore and consider the priorities of dental pre- assessment and the subsequent delivery of oral healthcare in the context of the different oncology treatment strategies utilised and in end-of-life care. The significant side effects of radiotherapy will be reviewed and clinical dental considerations presented using the existing evidence base and available guidelines. Ensuring mouth cancer does not result in dental disease is an important role for all members of the dental community. Introduction mouth cancer.2 While of seminal importance The dentist’s role in the journey of the prominence of these domains has often the mouth cancer patient Mouth cancer and its treatment have life overshadowed the important role of the dental changing effects on each and every individual team in the management of patients with head The dental practitioner and dental team diagnosed with the condition. -
A Clinical Guide on Causes, Effects and Treatments Guy Carpenter Editor
Guy Carpenter Editor Dry Mouth A Clinical Guide on Causes, E ects and Treatments Dry Mouth Guy Carpenter Editor Dry Mouth A Clinical Guide on Causes, Effects and Treatments Editor Guy Carpenter Department of Salivary Research Kings College London Dental Institute London UK ISBN 978-3-642-55153-6 ISBN 978-3-642-55154-3 (eBook) DOI 10.1007/978-3-642-55154-3 Springer Heidelberg New York Dordrecht London Library of Congress Control Number: 2014953246 © Springer-Verlag Berlin Heidelberg 2015 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recita- tion, broadcasting, reproduction on microfi lms or in any other physical way, and transmission or infor- mation storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifi cally for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher's location, in its current version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law. The use of general descriptive names, registered names, trademarks, service marks, etc. -
Dry Mouth and Sjã¶Gren's Syndrome: an Overview
DRY MOUTH AND SJÖGREN’S SYNDROME: AN OVERVIEW ABGEENA KHAN, PENELOPE J SHIRLAW Prim Dent J. 2 015; 4(2): 70-74 Causes of dry mouth 2,3 ABSTRACT There are many causes of dry mouth (Table 1). Drug-induced xerostomia is Dry mouth is a common condition presenting to a GP or general dental the most common cause, and there are practitioner. The most common cause of a dry mouth is related to medication use, more than 1,800 medicines that have however patients with Sjögren’s syndrome, a multisystem autoimmune condition, dry mouth as a listed side effect. 1,2 may present to their dentist rather than their GP complaining of dry mouth and dry The most common medicines include: eyes. This article explores the causes of dry mouth and how a patient can be • Antidepressants (Tricyclic investigated to find the cause of their dry mouth. An overview of Sjögren’s antidepressants, monoamine oxidases syndrome, the relevant diagnostic criteria, presenting signs and symptoms, and selective serotonin reuptake investigations and management principles are outlined. inhibitors). • Antihistamines. • Antihypertensives (ACE inhibitors, e.g. Ramipril; Beta blockers, e.g. erostomia (dry mouth) is extremely On average a person can produce Atenolol, Propranolol). common in the UK and affects 500ml of saliva over a 24 hour period. • Diuretics (Bendroflumethiazide). 1 Xabout 13% of the population. Saliva production increases considerably • Anti-reflux (Proton pump inhibitors Subjective xerostomia is the term used during eating producing on average e.g. Omeprazole). to describe the feeling of a dry mouth 2ml/min and reduces considerably • Anti-cholinergics (Atropine). -
Patient's Mouth
Mouth Care Matters Mouth Care Matters A guide for hospital healthcare professionals Developing people for health and healthcare www.hee.nhs.uk Version control Version: V12 Date ratified: 11 November 2016 Name and title of author Mili Doshi, Consultant in special care dentistry Date issued 11 November 2016 Review date November 2017 © 2016 Mouth Care Matters Contents A guide for health care professionals 1 Introduction 6 7 Dental decay (caries) 30 1.1 What is Mouth Care Matters in hospitals? 7 7.1 What is dental decay (caries)? 31 1.2 The Mouth Care Matters training programme 8 7.2 Signs of dental decay 31 1.3 Who is Mouth Care Matters training for? 8 7.3 Symptoms of dental decay 31 1.4 Mouth Care Matters team 8 7.4 Causes of dental decay 31 7.5 Prevention of dental decay 32 2 Why do we need Mouth Care Matters training? 10 7.6 Management of dental decay in hospitalised patients 32 2.1 What is the impact of hospitalisation on oral health? 11 8 Diet and oral health 33 2.2 We are a changing population 11 8.1 Effects of sugar in teeth 34 2.3 Our mouths are changing 11 8.2 Safe snacks 34 2.4 We are taking more medication 11 8.3 Sugar and medication 34 2.5 What are the barriers to providing good mouth 9 Fluoride 35 care in hospitals? 11 9.1 What is fluoride? 36 2.6 References 12 9.2 How does fluoride work? 36 3 Why is oral health important for 9.3 How much fluoride is enough? 36 hospitalised patients? 14 9.4 References 36 3.1 Definition of oral health 15 3.2 Oral hygiene and oral health 15 10 Tooth surface loss 37 10.1 What is tooth surface loss? -
Does Oral Dryness Influence Quality of Life? Current Perspectives in Elderly Dental Care
Original papers Does oral dryness influence quality of life? Current perspectives in elderly dental care Katarzyna Skośkiewicz-Malinowska1,A–D,F, Barbara Malicka1,A,B,D,F, Marek Ziętek2,A,D–F, Urszula Kaczmarek1,A,D–F 1 Department of Conservative Dentistry and Pedodontics, Wroclaw Medical University, Poland 2 Department of Periodontology, Wroclaw Medical University, Poland A – research concept and design; B – collection and/or assembly of data; C – data analysis and interpretation; D – writing the article; E – critical revision of the article; F – final approval of the article Advances in Clinical and Experimental Medicine, ISSN 1899–5276 (print), ISSN 2451–2680 (online) Adv Clin Exp Med. 2019;28(9):1209–1216 Address for correspondence Abstract Katarzyna Skośkiewicz-Malinowska E-mail: [email protected] Background. The oral condition can functionally, socially and psychologically influence the quality of life. Oral dryness often occurs in the elderly due to the presence of systemic diseases and medications, which Funding sources Municipal Office of Wroclaw favors the development of many lesions and complaints, including dental caries, candidiasis, retention of full removable denture, taste disturbance and it enforces a change in nutrition. Conflict of interest Objectives. The aim of this study was to assess the impact of oral dryness on oral health-related quality None declared of life in older subjects. Material and methods. Five hundred subjects of both genders, aged 65 and over (mean 74.4 ±7.4) were Received on October 25, 2018 involved in the study. Oral dryness was evaluated clinically with use of the Challacombe scale (CODS, Clinical Reviewed on November 27, 2017 Accepted on February 20, 2019 Oral Dryness Score). -
Study Title: an Evaluation of the Efficacy of 3M™ Dry Mouth Moisturizing Spray on the Relief of Dry Mouth Symptoms
Study Title: An Evaluation of the Efficacy of 3M™ Dry Mouth Moisturizing Spray on the Relief of Dry Mouth Symptoms NCT Number: NCT04186806 Document Date: 11 Jul 2019 Page 1 of 36 Status: Release Health Care Version: 3 3M Center Issue Date: 07/11/2019 03:08:44 PM CDT St. Paul, MN 55144-1000 Clinical Study Protocol EM-11-050038 Study Number and Protocol Title An Evaluation of the Efficacy of 3M™ Dry Mouth Moisturizing Spray on the Relief of Dry Mouth Symptoms Principal Investigator Yiming Li, DDS, MSD, PhD Distinguished Professor and Associate Dean for Research Sub-investigator (if applicable) So Ran Kwon, DDS, MS, PhD, MS Professor and Director of Student Research Program Montry Suprono, DDS, MSD Associate Professor and Director of Center for Dental Research Research Facility Loma Linda University, School of Dentistry Chan Shun Pavilion, CSP-A1010 11175 Campus Street Loma Linda, CA 92350 Telephone: 909-558-8178 FAX: 909-558-0328 Email: [email protected] IRB Loma Linda University 11234 Anderson Street Loma Linda, CA 92350 Sponsor 3M Health Care Oral Care Solutions Division St. Paul, MN 55144-1000 3M CRA Elaine A Egging, MT (ASCP) 3M Health Care 3M HCBG Clinical Operations 3M Center Building 270-4N-01 St. Paul, MN 55144-1000 Telephone: 651 737-0263 Email: [email protected] 3M Confidential Document Name: CLIN-PROT-ICH-US-11-406546 Clinical and Non-Clinical: CLIN-INDEX-3M-SPON-US-11-050038 Page 2 of 36 Status: Release Health Care Version: 3 3M Center Issue Date: 07/11/2019 03:08:44 PM CDT St. -
Penentuan Laju Alir Saliva Pada Pasien Geriatri Sebagai Pertimbangan Manajemen Komprehensif Pada Stomatitis Herpetika
Rafika : Penentuan laju alir saliva pada pasien… PENENTUAN LAJU ALIR SALIVA PADA PASIEN GERIATRI SEBAGAI PERTIMBANGAN MANAJEMEN KOMPREHENSIF PADA STOMATITIS HERPETIKA Mega Rafika*, Indah Suasani Wahyuni**,Wahyu Hidayat** *Residen Program Studi Ilmu Penyakit Mulut, FKG Universitas Padjajaran **Bagian Ilmu Penyakit Mulut, FKG Universitas Padjajaran Jl. Sekeloa Selatan I, Lebak Gede, Coblong, Bandung Email: [email protected] KATA KUNCI ABSTRAK Geriatri, Stomatitis Latar belakang Laju saliva adalah sekresi saliva yang dinyatakan herpetika,Laju Saliva. dalam ml/menit. Pada pasien geriatri dengan riwayat hipertensi dapat menurunkan kuantitas, kualitas dan laju saliva. Kondisi ini dapat meningkatkan terjadinya infeksi rongga mulut seperti stomatitis herpetika.Tujuan Mengukur laju saliva pada pasien geriatri dengan riwayat hipertensi yang didiagnosa stomatitis herpetika, keilitis eksfoliatif dan hiposalivasi sebagai pertimbangan perawatan yang komprehensif. Laporan kasus Seorang wanita usia 63 tahun datang ke klinik karena sariawan selama beberapa tahun dan mengganggu sejak 2 bulan yang lalu. Pemeriksaan ekstraoral berupa bibir kering. Pemeriksaan intraoral menunjukkan oral hygiene buruk, kondisi mukosa oral yang kering dan terdapat ulser multipel. Pemeriksaan laboratorium menunjukkan eosinofil dan monosit di bawah normal, dan IgG anti HSV-1 reaktif. Laju saliva 0,2 ml/menit, dilakukan dengan metode spitting untuk menegakkan diagnosa hiposalivasi. Penatalaksanaan kasus Pasien diberikan vitamin B12, asam folat untuk meningkatkan daya tahan tubuh, Vaseline album untuk melembabkan bibir, chlorhexidine gluconate 0,2%, oral hygiene instruction dan scalling dilakukan untuk memperbaiki oral hygiene serta disarankan nutrisi seimbang dan hidrasi yang memadai sebagai terapi nonfarmakologi. Diskusi Pasien ini memiliki kondisi yang kompleks: geriatri, oral hygiene yang buruk, menggunakan obat antihipertensi, dan juga mengalami stres emosional.